* Biostage appoints Harout Dersimonian, PH.D. as chief
scientific officer to oversee cell biology, materials science
and other research underlying its organ implant development
The post BRIEF-Biostage says cellspan implants being advanced, tested in preclinical studies appeared first on NASDAQ.